EMEA-001799-PIP03-19
Key facts
| Active substance |
The whole range of unmanipulated autologous mononuclear cells derived from human umbilical cord blood (Hau-UCB-mnc)
|
| Therapeutic area |
Neonatology-Paediatric Intensive Care
|
| Decision number |
P/0385/2020
|
| PIP number |
EMEA-001799-PIP03-19
|
| Pharmaceutical form(s) |
Suspension for infusion
|
| Condition(s) / indication(s) |
Treatment of periventricular leukomalacia
|
| Route(s) of administration |
Intravenous use
|
| Contact for public enquiries |
BrainRepair UG (haftungsbeschränkt)
E-mail: arne.jensen@brainrepair.eu |
| Decision type |
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
|